ACRS Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development SCZM Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Edges Higher FENC Q1 2026 Earnings Unexpected Profitability Surprises Market Stock Edges Lower Genmab GMAB Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Data Unavailable NextCure Inc NXTC Q1 2026 Earnings EPS Beat Amid No Revenue and Steep Stock Decline